DaTscan (Ioflupane I 123 Injection) for Parkinsonian Syndrome

Course overview

This course covers the official drug name, clinical indications, and a technical description of this diagnostic radiopharmaceutical; a description of the emissive properties of I-123 and information regarding its penetrability in human tissue; contraindications and side effects and adverse reactions related to this drug; dose administration procedure; imaging procedures; pharmacology; and internal radiation dosimetry associated with the administration of DATSCAN After completion of this tutorial, one should be able to list the primary indication for diagnostic use of DATSCAN; identify the route of administration, the typical prescribed dose, and the clinical pharmacology; describe the radiolabeling procedure and the method of assessing quality control; describe imaging protocols; identify normal and abnormal images; and give a brief summary of internal radiation dosimetry following administration of DATSCAN